TETRAPHASE PHARMACEUTICALS INC Lease, Cost
TETRAPHASE PHARMACEUTICALS INC reported Lease, Cost of $569.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2020-05-07
- TETRAPHASE PHARMACEUTICALS INC lease, cost for the quarter ending 2020-03-31 was $569.00K, a 26.10% decline year-over-year.
- TETRAPHASE PHARMACEUTICALS INC lease, cost for the quarter ending 2019-12-31 was $784.00K.
- TETRAPHASE PHARMACEUTICALS INC lease, cost for the quarter ending 2019-09-30 was $788.00K.
- TETRAPHASE PHARMACEUTICALS INC lease, cost for the quarter ending 2019-06-30 was $757.00K.
- TETRAPHASE PHARMACEUTICALS INC lease, cost for fiscal 2019 was $3.10M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2020-03-31 | $569.00K 10-Q · filed 2020-05-07 | $1.35M derived: sum of 2 quarters · filed 2020-05-07 | $2.14M derived: sum of 3 quarters · filed 2020-05-07 | $2.90M derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | $784.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $1.57M derived: sum of 2 quarters · filed 2020-03-12 | $2.33M derived: sum of 3 quarters · filed 2020-03-12 | $3.10M 10-K · filed 2020-03-12 |
| 2019-09-30 | $788.00K 10-Q · filed 2019-11-12 | $1.54M derived: sum of 2 quarters · filed 2019-11-12 | $2.32M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $757.00K 10-Q · filed 2019-08-08 | $1.53M 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | $770.00K 10-Q · filed 2020-05-07 |